摘要:
Disclosed are: a compound which is stable in an acid, has an antibacterial effect against a bacterium Helicobacter pylori, can exert a satisfactory level of an antibacterial effect when used singly, does not affect an enteric bacterium, has an antibacterial effect against a bacterium resistant to an antibacterial agent, and has an inhibitory effect on gastric acid secretion; and a pharmaceutical composition comprising the compound. Specifically disclosed are: a compound represented by the general formula (I) or a salt thereof; and a pharmaceutical composition comprising the compound or the salt thereof: wherein R represents a linear alkyl group having 4 to 8 carbon atoms, preferably 5 to 7 carbon atoms.
摘要:
A compound represented by formula (I): [wherein, for example, X is a hydrogen atom or a halogen atom; R1 is a hydrogen atom; R2 is a hydrogen atom or a C1-4 alkyl group; R3 is —CHO or —COOH; and R4 is —CH═CH—(CH2)p—CH3 (wherein p is an integer of 1 to 12), —CH(OH)—(CH2)q—CH3 (wherein q is an integer of 1 to 13), —CH(OH)—CH2—CH(CH3)—(CH2)2—CH═C(CH3)2, —CH═CH—CH(CH3)—(CH2)3—CH(CH3)2, —(CH2)2—CH(CH3)—(CH2)3—CH(CH3)2 or —(CH2)8—CH3], an optical isomer thereof and a pharmaceutically acceptable salt thereof. These compounds have antitrypanosoma activity, and accordingly are useful as drugs for preventing or treating the diseases caused by trypanosoma.
摘要:
A .beta.,.gamma.-dihydropolyprenyl alcohol derivative having the formula: ##STR1## wherein n is an integer of 5 to 7 and R is hydrogen, a lower alkyl group or an aliphatic or aromatic acyl group, is new and useful as a prophylactic therapeutic agent for human and animal immuno-deficiency deseases and phylactic agent against human and animal infectious deseases. Another disclosed polyprenyl compound is also useful as the same agent.
摘要:
Novel compounds below are useful for preventing or treating diseases caused by protozoans. At least one of a compound represented by Formula (I) (wherein, X represents a hydrogen atom or a halogen atom; R1 represents a hydrogen atom; R2 represents a hydrogen atom or a C1-7 alkyl group; R3 represents —CHO, —C(═O)R5, —COOR5 (wherein R5 represents a C1-7 alkyl group), —CH2OH or —COOH; and R4 represents a C1-16 alkyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s), a C2-16 alkenyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s), or a C2-16 alkynyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s)), an optical isomer thereof, and a pharmaceutically acceptable salt is used.
摘要:
A method for the treatment and prevention of herpes zoster using 5-[(E)-2-halogenovinyl]arabinofuranosyl uracil of the following general formula (1): wherein X represents a halogen atom.
摘要:
Novel compounds below are useful for preventing or treating diseases caused by protozoans. At least one of a compound represented by Formula (I) (wherein, X represents a hydrogen atom or a halogen atom; R1 represents a hydrogen atom; R2 represents a hydrogen atom or a C1-7 alkyl group; R3 represents —CHO, —C(═O)R5, —COOR5 (wherein R5 represents a C1-7 alkyl group), —CH2OH or —COOH; and R4 represents a C1-16 alkyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s), a C2-16 alkenyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s), or a C2-16 alkynyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s)), an optical isomer thereof, and a pharmaceutically acceptable salt is used.
摘要:
Disclosed are a novel pyridine thio derivative, and a pharmaceutical composition using the novel pyridine thio derivative, particularly a pharmaceutical composition having selective antibacterial activity against Helicobacter pylori. Specifically disclosed is a pyridine thio derivative represented by general formula (I) (wherein R1 and R2 each represents a hydrogen atom, a C1-8 alkyl group or the like; R3 and R4 each represents a hydrogen atom, a C1-8 alkyl group or the like; X represents —O—, —S— or the like; Y represents a C1-12 alkyl group which may be substituted by a substituent or —(R5—O)n—R6 (wherein R5 represents a C1-5 alkylene group; R6 represents a C1-8 alkyl group which may be substituted by a substituent, and n represents an integer of 1-10); and Z represents a hydrogen atom or the like), or a pharmacologically acceptable salt thereof. Also specifically disclosed is a pharmaceutical composition containing the pyridine thio derivative or a salt thereof.
摘要翻译:公开了一种新的吡啶硫代衍生物,以及使用新型吡啶硫代衍生物的药物组合物,特别是对幽门螺杆菌具有选择性抗菌活性的药物组合物。 具体公开的是由通式(I)表示的吡啶硫代衍生物(其中R 1和R 2各自表示氢原子,C 1-8烷基等; R 3和R 4各自表示氢原子,C 1-8烷基 X表示-O-,-S-等; Y表示可以被取代基取代的C1-12烷基或 - (R5-O)n-R6(其中R5表示C1-5 亚烷基; R 6表示可被取代基取代的C 1-8烷基,n表示1-10的整数),Z表示氢原子等)或其药理学上可接受的盐。 还具体公开了含有吡啶硫代衍生物或其盐的药物组合物。
摘要:
The object is to provide an excellent pharmaceutical having an anti-Helicobacter pylori activity. Disclosed is a novel pyridine derivative represented by the following general formula (I): wherein R represents a linear or branched hydroxyalkyl group having 5 to 10 carbon atoms, or a pharmaceutically acceptable salt thereof, which has a potent antibacterial activity against H. pyroli (Helicobacter pyroli) Examples of the disease which can be prevented/treated by administration of a pharmaceutical agent comprising the compound include gastritis, gastric ulcer, duodenal ulcer, gastric MALT lymphoma, gastric hyperplastic polyp, development of gastric cancer after endoscopic resection of the early stage of gastric cancer and the like.
摘要:
A milking apparatus comprises sets of electrodes for detecting milk flows sucked by individual teat cups capped on individual teats, tubes connected to pressure chambers of the respective teat cups, change-over valves operative to supply atmospheric pressure and vacuum periodically and alternately to the tubes, counters for counting times for non-detection of the milk flows by the sets of electrodes, and controller for actuating the change-over valves to supply only atmospheric pressure to the tubes when the counted times of the counters exceed a predetermined time.
摘要:
A milk-claw includes a collecting chamber for milk is formed within a drum housing and connected to inlets and an outlet for milk respectively; inspection chambers for milk which have been defined adjacent to said collecting chamber for milk by means of a partition wall and in which part of the milk flowing in the collecting chamber for milk through said inlets flows; and electrodes for measuring the electric conductivity of the milk flowed in said inspection chambers for milk; wherein a through hole is perforated in said partition wall interposed between said collecting chamber for milk and inspection chambers so that the milk flowed in said inspection chambers for milk may flow back in the collecting chamber.